Literature DB >> 15070791

Impracticability of informed consent in the Registry of the Canadian Stroke Network.

Jack V Tu1, Donald J Willison, Frank L Silver, Jiming Fang, Janice A Richards, Andreas Laupacis, Moira K Kapral.   

Abstract

BACKGROUND: Government legislators and research ethics boards in some jurisdictions require all patients to give written informed consent before enrollment in clinical registries. However, the effect of such a requirement on the use of clinical registries and the extent to which registry data can be generalized remain uncertain.
METHODS: We examined the effectiveness of a comprehensive attempt to obtain informed consent between June 2001 and December 2002 on the overall participation rate and the characteristics of participating patients in the Registry of the Canadian Stroke Network, a prospective registry based at 20 major stroke centers across Canada.
RESULTS: The overall participation rate (i.e., the consent rate among all potential participants) was 39.3 percent of 4285 eligible patients during phase 1 of the project (June 2001 through February 2002) and 50.6 percent of 2823 eligible patients during phase 2 (June 2002 through December 2002), despite the presence of neurologic research nurse coordinators at each site. Many patients died or left the hospital before they could be approached for consent. Major selection biases were found; the in-hospital mortality rate was much lower among patients who were enrolled (6.9 percent) than among those who were not enrolled (21.7 percent) (relative risk of in-hospital death, 3.13; 95 percent confidence interval, 2.65 to 3.70; P<0.001). We estimate that approximately 500,000 dollars (Canadian dollars) was spent on consent-related issues during the first two years of the registry.
CONCLUSIONS: Obtaining written informed consent for participation in a stroke registry led to important selection biases, such that registry patients were not representative of the typical patient with stroke at each center. These findings highlight the need for legislation on privacy and policies permitting waivers of informed consent for minimal-risk observational research. Copyright 2004 Massachusetts Medical Society

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2004        PMID: 15070791     DOI: 10.1056/NEJMsa031697

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  115 in total

1.  Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.

Authors:  Robert W Yeh; Matthew J Czarny; Sharon-Lise T Normand; Dean J Kereiakes; David R Holmes; Ralph G Brindis; W Douglas Weaver; John S Rumsfeld; Matthew T Roe; Sunghee Kim; Priscilla Driscoll-Shempp; Laura Mauri
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-11-16

2.  Passive consent for clinical research in the age of HIPAA.

Authors:  Benjamin Littenberg; Charles D MacLean
Journal:  J Gen Intern Med       Date:  2006-03       Impact factor: 5.128

3.  Randomized trial showed that an "embedded" survey strategy optimized authorization rates compared with two "after survey" strategies in veterans with PTSD.

Authors:  Maureen Murdoch; Diane M Pietila; Melissa R Partin
Journal:  J Clin Epidemiol       Date:  2010-03-21       Impact factor: 6.437

4.  Long-term trajectory of leisure time physical activity and survival after first myocardial infarction: a population-based cohort study.

Authors:  Yariv Gerber; Vicki Myers; Uri Goldbourt; Yael Benyamini; Mickey Scheinowitz; Yaacov Drory
Journal:  Eur J Epidemiol       Date:  2010-11-30       Impact factor: 8.082

Review 5.  Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet).

Authors:  Emily P Zeitler; Sana M Al-Khatib; Joseph P Drozda; Larry G Kessler; Ajay J Kirtane; David F Kong; John Laschinger; Danica Marinac-Dabic; Marie-Claude Morice; Terrie Reed; Art Sedrakyan; Kenneth M Stein; James Tcheng; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2015-07-30       Impact factor: 4.749

6.  Coordination and management of multicenter clinical studies in trauma: Experience from the PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) Study.

Authors:  Mohammad H Rahbar; Erin E Fox; Deborah J del Junco; Bryan A Cotton; Jeanette M Podbielski; Nena Matijevic; Mitchell J Cohen; Martin A Schreiber; Jiajie Zhang; Parsa Mirhaji; Sarah J Duran; Robert J Reynolds; Ruby Benjamin-Garner; John B Holcomb
Journal:  Resuscitation       Date:  2011-10-12       Impact factor: 5.262

7.  The Lombardia Stroke Unit Registry: 1-year experience of a web-based hospital stroke registry.

Authors:  Giuseppe Micieli; Anna Cavallini; Silvana Quaglini; Giancarlo Fontana; Michela Duè
Journal:  Neurol Sci       Date:  2010-03-26       Impact factor: 3.307

8.  A national strategy for waiting-times research?

Authors:  Pamela M Slaughter; John Carlisle; Jack Williams; Lorraine E Ferris
Journal:  CMAJ       Date:  2005-05-10       Impact factor: 8.262

9.  Survey of informed consent for registration of congenital anomalies in Europe.

Authors:  Araceli Busby; Annukka Ritvanen; Helen Dolk; Nicola Armstrong; Hermien De Walle; Isolina Riaño-Galán; Miriam Gatt; Robert McDonnell; Vera Nelen; David Stone
Journal:  BMJ       Date:  2005-07-16

10.  Can current electronic systems meet drug safety and effectiveness requirements?

Authors:  Anne Holbrook; Paul Grootendorst; Don Willison; Charles Goldsmith; Rolf Sebaldt; Karim Keshavjee
Journal:  AMIA Annu Symp Proc       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.